RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 70 filers reported holding RECRO PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $749,430 | -57.4% | 1,597,931 | 0.0% | 0.01% | -61.5% |
| Q2 2023 | $1,757,724 | -7.6% | 1,597,931 | 0.0% | 0.01% | -23.5% |
| Q1 2023 | $1,901,538 | -51.8% | 1,597,931 | -39.6% | 0.02% | -58.5% |
| Q4 2022 | $3,941,412 | +126.4% | 2,645,243 | +147.6% | 0.04% | +105.0% |
| Q3 2022 | $1,741,000 | +105.1% | 1,068,386 | 0.0% | 0.02% | +100.0% |
| Q2 2022 | $849,000 | -62.2% | 1,068,386 | -14.5% | 0.01% | -60.0% |
| Q1 2022 | $2,249,000 | -26.8% | 1,249,226 | -30.5% | 0.02% | -28.6% |
| Q4 2021 | $3,072,000 | -12.4% | 1,796,720 | +5.5% | 0.04% | -18.6% |
| Q3 2021 | $3,508,000 | -20.6% | 1,702,720 | -11.0% | 0.04% | -15.7% |
| Q2 2021 | $4,418,000 | +155.7% | 1,912,685 | +208.9% | 0.05% | +131.8% |
| Q1 2021 | $1,728,000 | -17.7% | 619,285 | -16.0% | 0.02% | -26.7% |
| Q4 2020 | $2,100,000 | +5.9% | 736,821 | -22.0% | 0.03% | 0.0% |
| Q3 2020 | $1,983,000 | +99.9% | 944,377 | +333.2% | 0.03% | +100.0% |
| Q2 2020 | $992,000 | -79.0% | 217,977 | -53.1% | 0.02% | -75.4% |
| Q2 2019 | $4,724,000 | -15.2% | 464,510 | -51.1% | 0.06% | -17.6% |
| Q1 2019 | $5,572,000 | -18.6% | 950,874 | -1.4% | 0.07% | -26.0% |
| Q4 2018 | $6,844,000 | +3.1% | 964,000 | +3.2% | 0.10% | +37.0% |
| Q3 2018 | $6,639,000 | +46.8% | 933,696 | +3.6% | 0.07% | +78.0% |
| Q2 2018 | $4,523,000 | -51.7% | 900,982 | +5.9% | 0.04% | -47.4% |
| Q1 2018 | $9,365,000 | +0.5% | 850,570 | -15.6% | 0.08% | +5.4% |
| Q4 2017 | $9,323,000 | +14.5% | 1,007,853 | +11.2% | 0.07% | +21.3% |
| Q3 2017 | $8,139,000 | +32.1% | 906,398 | +3.4% | 0.06% | +17.3% |
| Q2 2017 | $6,162,000 | -6.3% | 876,599 | +16.5% | 0.05% | -1.9% |
| Q1 2017 | $6,579,000 | -5.4% | 752,729 | -12.8% | 0.05% | -8.6% |
| Q4 2016 | $6,954,000 | +1425.0% | 862,761 | +1571.4% | 0.06% | +1350.0% |
| Q3 2016 | $456,000 | – | 51,619 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |